The changing face of corporate venturing in biotechnology | Pharmaceutics_R&D |
Corporate venture funds are playing an increasingly important role in supporting life science commercialization. 

Corporate venturing—the practice of establishing a unit of a corporation with the mandate to make strategic investments in entrepreneurial ventures—has emerged as one of the most prominent strategies for opening up innovation to external ideas and knowledge in the life sciences. Venture arms of pharmaceutical and large biotech companies leverage capital surplus generated through traditional revenue streams to create options for future product pipelines, enable access to innovative compounds and share the costs of risky early stage development with external partners. (...) - von Krogh G et al.Nature Biotechnology 30, 911–915 (2012)